Department of Otorhinolaryngology, University Medical Centre Utrecht, The Netherlands.
Otolaryngol Head Neck Surg. 2011 Jan;144(1):5-9. doi: 10.1177/0194599810390914.
In this evidence based case report we addressed the clinical question: which factors predict the occurrence of a pharyngocutaneous fistula after total laryngectomy in patients that already were treated with radiotherapy for a squamous cell carcinoma of the larynx? We searched for relevant synonyms for the domain, being patients earlier treated with radiotherapy for a squamous cell carcinoma of the larynx and having a recurrence for which a salvage total laryngectomy is necessary, with the outcome being the development of a post-operative pharyngocutaneous fistula. We searched for relevant publications in Embase, Pubmed and Web of Science using search terms in title and abstract fields. The search yielded 1764 records, of which three were relevant and valid for our clinical question. Our results show that the absolute risk of a pharyngocutaneous fistula after total laryngectomy in patients earlier treated with radiotherapy for a squamous cell carcinoma of the larynx mainly depends on characteristics and site of the primary tumor. In patients who have a primary glottic laryngeal T1 or T2 tumor the absolute risk of developing a fistula is 11% (95% CI 6; 15%), whereas the risk of developing a fistula in patients with a T3 or T4 extra laryngeal tumor is 35% (95% CI 25; 46%). Other patient and surgical characteristics can however not be ruled out as important prognostic factors since many of them have to date not been studied, e.g. diabetes mellitus, alcohol consumption, smoking, suture materials and surgical technique used.
在本基于证据的病例报告中,我们解决了临床问题:已经接受放疗治疗声门鳞状细胞癌的患者,哪些因素预测全喉切除术后咽瘘的发生?我们搜索了与领域相关的同义词,即先前接受放疗治疗声门鳞状细胞癌且需要挽救性全喉切除术治疗复发的患者,其结果是术后发生咽瘘。我们使用标题和摘要字段中的搜索词在 Embase、Pubmed 和 Web of Science 中搜索相关出版物。搜索产生了 1764 条记录,其中有 3 条与我们的临床问题相关且有效。我们的结果表明,先前接受放疗治疗声门鳞状细胞癌的患者在全喉切除术后发生咽瘘的绝对风险主要取决于原发肿瘤的特征和部位。对于原发于声带的 T1 或 T2 声门型喉肿瘤患者,发生瘘的绝对风险为 11%(95%CI 6%;15%),而原发于声门旁或声门上型喉肿瘤的 T3 或 T4 期肿瘤患者发生瘘的风险为 35%(95%CI 25%;46%)。然而,其他患者和手术特征不能排除作为重要的预后因素,因为迄今为止,许多因素尚未得到研究,例如糖尿病、酒精摄入、吸烟、缝线材料和使用的手术技术。